Related Experiment Video
Updated: Jul 13, 2025

07:13
Digital Home-Monitoring of Patients after Kidney Transplantation: The MACCS Platform
Published on: April 12, 2021
4.3K
Design of an interface to communicate artificial intelligence-based prognosis for patients with advanced solid
Catherine J Staes1,2, Anna C Beck3, George Chalkidis4
1College of Nursing, University of Utah, Salt Lake City, UT 84112, United States.
Journal of the American Medical Informatics Association : JAMIA
|October 17, 2023
Summary
This study developed a user-centered interface to help oncologists communicate machine learning (ML)-based prognosis for advanced solid tumors. The design prioritizes interpretability and trust, improving patient-doctor discussions about cancer survival predictions.
Area of Science:
- Oncology
- Medical Informatics
- Human-Computer Interaction
Background:
- Communicating machine learning (ML)-based prognosis for advanced solid tumors presents challenges for oncologists.
- Existing tools may not adequately address the need for clear, interpretable prognostic information in clinical practice.
Purpose of the Study:
- To design and refine an interface that supports oncologists in communicating ML-based prognosis.
- To incorporate oncologists' needs and feedback throughout the design process using a user-centered approach.
Main Methods:
- Employed an interdisciplinary, user-centered design approach with 5 iterative design rounds.
- Conducted expert reviews, incorporated feedback from a color-blind adult, and performed 13 semi-structured interviews with oncologists.
- Utilized patient vignettes and interfaces with representative data to gather feedback on predicted survival for treatment decision points.
Main Results:
- Developed a 7-section interface enabling oncologists to "tell a story" about prognosis.
- Iterative enhancements addressed user-focused questions, improved communication of ML-based prognosis, and exposed design assumptions.
- Clinicians prioritized interpretability over explainability, requesting specific usability and trust enhancements (e.g., using months instead of days, addressing prior treatments).
Conclusions:
- User-centered design and ongoing clinical input are crucial for developing effective AI-enabled decision support tools.
- Visualizations that clearly communicate ML-related outcomes are essential, especially for conveying prognosis risk.
- The designed interface aims to enhance trust and understanding in ML-driven prognostic communication between oncologists and patients.
Related Concept Videos
Cancer Survival Analysis
357
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
357
Tumor Immunotherapy
538
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
538
Tumor Progression
6.3K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.3K
Mouse Models of Cancer Study
5.6K
Mice have long served as models for studying human biology and pathology because of their phylogenetic and physiological similarity with humans. They are also easy to maintain and breed in the laboratory, and hence, many inbred strains are now available for research. Studies on mice have contributed immeasurably to our understanding of cancer biology.
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
5.6K
Adaptive Mechanisms in Cancer Cells
5.8K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.8K

